Award Categories include Device Design, Innovation and Leadership which recognize achievements in manufacturing, technology, materials and team performance.
Companies spoke about the need for navigation, robotics and AI at NASS 2024.
Outpatient surgery is the vanguard of modern healthcare and the future of surgical and medical innovation, says an ASC investor.
Vizient launched a first-of-its-kind sourcing program that targets ASCs. The initiative serves as an example of the evolving opportunities the ASC market will open for industry in the years ahead.
All metal MedCAD products, including AccuPlate plates and AccuShape Ti cranioplasty products, will now be fully converted to 3D titanium printing technology only.
The companies entered an agreement to codevelop and market Gel-One hyaluronate injection for the treatment of osteoarthritis in Japan.
Lovell Government Services will serve as NovApproach Spine’s Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor.
The federal government’s sweeping changes have created complexity and uncertainty for the medical device industry.
AI is setting standards for predictive analysis and surgical precision in a way that elevates the surgeons’ performance and patient outcomes.
This enables Medartis to offer surgeons both replacement and reconstruction solutions for elbow procedures.
Alpha Medical will have exclusive distribution rights in New Zealand for Tetrous EnFix demineralized bone fiber implants.
Award Categories include Device Design, Innovation and Leadership which recognize achievements in manufacturing, technology, materials and team performance.
Industry and surgeons attending the AAOS Annual Meeting spoke with optimism about market growth and new technology.
Kolosis has grown the portfolio of MTF Biologics allografts it represents to include DBX Mix and DBX Putty.
A group of investors has been designated as the winning bidder to acquire substantially all of Exactech’s assets.
OsteoCentric’s MIS Bone Preservation Tapping Technology & Instant Interlocking Thread-form is the first implant-to-bone interface to support primary implant stability over time.
Amplitude Surgical develops and markets orthopedic implants, covering the main pathologies affecting the hip and knee.
The transaction will accelerate Medacta’s sports medicine offering and bring additional U.S. sales agents and distributors in over 45 countries.
Login
Register for a free account
As a guest member you get access to more articles and videos every month.